TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $298,439 | -6.8% | 23,063 | 0.0% | 0.12% | -7.5% |
Q1 2024 | $320,349 | -2.7% | 23,063 | 0.0% | 0.13% | -14.2% |
Q4 2023 | $329,113 | -9.8% | 23,063 | -2.2% | 0.16% | -17.1% |
Q3 2023 | $364,957 | -1.7% | 23,591 | -0.2% | 0.19% | -12.6% |
Q2 2023 | $371,400 | -4.7% | 23,640 | -0.0% | 0.21% | -16.7% |
Q1 2023 | $389,604 | +5.8% | 23,641 | +0.2% | 0.26% | -7.2% |
Q4 2022 | $368,099 | +21.9% | 23,596 | +1.3% | 0.28% | +27.6% |
Q3 2022 | $302,000 | -5.6% | 23,287 | +1.9% | 0.22% | +50.7% |
Q2 2022 | $320,000 | -1.2% | 22,849 | +0.9% | 0.14% | -19.6% |
Q1 2022 | $324,000 | -9.0% | 22,639 | -13.5% | 0.18% | -5.3% |
Q4 2021 | $356,000 | -39.5% | 26,170 | -27.2% | 0.19% | -27.0% |
Q3 2021 | $588,000 | +81.5% | 35,950 | +86.7% | 0.26% | +42.3% |
Q2 2021 | $324,000 | -7.7% | 19,259 | 0.0% | 0.18% | -19.1% |
Q1 2021 | $351,000 | +42.7% | 19,259 | +42.0% | 0.22% | +21.6% |
Q4 2020 | $246,000 | +1.7% | 13,564 | -0.0% | 0.18% | -8.0% |
Q3 2020 | $242,000 | -12.6% | 13,569 | -12.2% | 0.20% | -24.4% |
Q2 2020 | $277,000 | +16.4% | 15,450 | -1.6% | 0.27% | -6.7% |
Q1 2020 | $238,000 | -27.9% | 15,701 | -6.4% | 0.28% | -14.4% |
Q4 2019 | $330,000 | +13.0% | 16,781 | -1.2% | 0.33% | -6.5% |
Q3 2019 | $292,000 | -7.9% | 16,985 | -5.3% | 0.36% | -9.0% |
Q2 2019 | $317,000 | – | 17,936 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |